News

COURAGE Patients Lacked High-Risk Lesions


 

Dr. Teirstein reported receiving grant support from and serving as a consultant to Cordis Corp., Boston Scientific Corp., Abbott Laboratories, and Medtronic Inc. He also receives royalty income from Boston Scientific.

Pages

Recommended Reading

Tailored Clopidogrel Cut Adverse Events After PCI
MDedge Cardiology
Cyclosporine May Limit Infarct Size
MDedge Cardiology
Eptifibatide Increased Bleeding, Added No Benefit in ASSIST
MDedge Cardiology
Proximal Protection Spurs STEMI Resolution
MDedge Cardiology
Prolonged Bivalirudin Infusion Reduced PCI-Related MIs
MDedge Cardiology
Medical, Surgical Therapies Yield Similar Outcomes
MDedge Cardiology
Patients Over 80 Do Well After Cardiac Surgery
MDedge Cardiology
Pretest Predicted ACS in Low-Risk Patients
MDedge Cardiology
Perioperative β-Blockade May Raise Stroke Risk
MDedge Cardiology
FDA Says Bisphosphonates Not Tied to Atrial Fib
MDedge Cardiology